These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36318366)

  • 1. Transplantation of Differentiated Tonsil-Derived Mesenchymal Stem Cells Ameliorates Murine Duchenne Muscular Dystrophy via Autophagy Activation.
    Park S; Jeong S; Nam YH; Yum Y; Jung SC
    Tissue Eng Regen Med; 2022 Dec; 19(6):1283-1294. PubMed ID: 36318366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model.
    Siemionow M; Szilagyi E; Cwykiel J; Domaszewska-Szostek A; Heydemann A; Garcia-Martinez J; Siemionow K
    Stem Cells Dev; 2021 Feb; 30(4):190-202. PubMed ID: 33349121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
    Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
    Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.
    Siemionow M; Langa P; Harasymczuk M; Cwykiel J; Sielewicz M; Smieszek J; Heydemann A
    Stem Cells Transl Med; 2021 Oct; 10(10):1406-1418. PubMed ID: 34291884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A
    Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial Ablation of Non-Myogenic Progenitor Cells as a Therapeutic Approach to Duchenne Muscular Dystrophy.
    Gao Z; Lu A; Daquinag AC; Yu Y; Huard M; Tseng C; Gao X; Huard J; Kolonin MG
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory amnion-derived mesenchymal stromal cells preserve muscle function in a mouse model of Duchenne muscular dystrophy.
    Nitahara-Kasahara Y; Nakayama S; Kimura K; Yamaguchi S; Kakiuchi Y; Nito C; Hayashi M; Nakaishi T; Ueda Y; Okada T
    Stem Cell Res Ther; 2023 Apr; 14(1):108. PubMed ID: 37106393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR).
    Elhussieny A; Nogami K; Sakai-Takemura F; Maruyama Y; Takemura N; Soliman WT; Takeda S; Miyagoe-Suzuki Y
    Stem Cell Res Ther; 2021 Oct; 12(1):532. PubMed ID: 34627382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy.
    Chesshyre M; Ridout D; Hashimoto Y; Ookubo Y; Torelli S; Maresh K; Ricotti V; Abbott L; Gupta VA; Main M; Ferrari G; Kowala A; Lin YY; Tedesco FS; Scoto M; Baranello G; Manzur A; Aoki Y; Muntoni F
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1360-1372. PubMed ID: 35083887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy.
    Bier A; Berenstein P; Kronfeld N; Morgoulis D; Ziv-Av A; Goldstein H; Kazimirsky G; Cazacu S; Meir R; Popovtzer R; Dori A; Brodie C
    Biomaterials; 2018 Aug; 174():67-78. PubMed ID: 29783118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-Transplantation of Bone Marrow-MSCs and Myogenic Stem/Progenitor Cells from Adult Donors Improves Muscle Function of Patients with Duchenne Muscular Dystrophy.
    Klimczak A; Zimna A; Malcher A; Kozlowska U; Futoma K; Czarnota J; Kemnitz P; Bryl A; Kurpisz M
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral Micro-dystrophin Gene Treatment into Late-stage mdx Mice for Duchenne Muscular Dystrophy Disease.
    Eren SA; Tastan C; Karadeniz KB; Turan RD; Cakirsoy D; Kancagi DD; Yilmaz SU; Oztatlici M; Oztatlici H; Ozer S; Tumentemur G; Baykal AT; Ovali E
    Curr Gene Ther; 2023; 23(4):304-315. PubMed ID: 37032509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells isolated from human dental pulp and amniotic fluid improve skeletal muscle histopathology in mdx/SCID mice.
    Pisciotta A; Riccio M; Carnevale G; Lu A; De Biasi S; Gibellini L; La Sala GB; Bruzzesi G; Ferrari A; Huard J; De Pol A
    Stem Cell Res Ther; 2015 Aug; 6(1):156. PubMed ID: 26316011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-Based Dystrophin Restoration Reveals a Novel Role for Dystrophin in Bioenergetics and Stress Resistance of Muscle Progenitors.
    Matre PR; Mu X; Wu J; Danila D; Hall MA; Kolonin MG; Darabi R; Huard J
    Stem Cells; 2019 Dec; 37(12):1615-1628. PubMed ID: 31574188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model.
    Siemionow M; Brodowska S; Langa P; Zalants K; Kozlowska K; Grau-Kazmierczak W; Heydemann A
    Arch Immunol Ther Exp (Warsz); 2022 Aug; 70(1):20. PubMed ID: 35978142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation.
    Cui CH; Uyama T; Miyado K; Terai M; Kyo S; Kiyono T; Umezawa A
    Mol Biol Cell; 2007 May; 18(5):1586-94. PubMed ID: 17314403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy.
    Meng J; Counsell JR; Reza M; Laval SH; Danos O; Thrasher A; Lochmüller H; Muntoni F; Morgan JE
    Sci Rep; 2016 Jan; 6():19750. PubMed ID: 26813695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.